Growth HormonePreclinical Evidence

MGF

Also known as: Mechano Growth Factor, IGF-1Ec

Splice variant of IGF-1 released in response to mechanical stress that promotes muscle repair and growth.

Benefits

5

Conditions

5

Evidence

Preclinical studies, limited human data+ studies

Source

Synthetic IGF-1Ec splice variant

Overview

Splice variant of IGF-1 released in response to mechanical stress that promotes muscle repair and growth.

Mechanism of Action

IGF-1 splice variant activated by muscle damage, activates satellite cells for repair, promotes local muscle growth and regeneration, synergizes with systemic IGF-1 for enhanced hypertrophy.

Key Benefits

  • Muscle repair and recovery
  • Satellite cell activation
  • Local muscle growth
  • Enhanced recovery from training
  • Synergy with IGF-1

Clinical Applications

Muscle injuryPost-workout recoveryMuscle wastingAthletic performanceAge-related muscle loss

Dosing Guidelines

Intramuscular injection (site-specific)

Typical Dose200-400 mcg
FrequencyPost-workout, 2-3 times per week
Duration4-6 weeks

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Preclinical
Studies

Preclinical studies, limited human data

Summary

Mechanism understood from IGF-1 research. No human clinical trials. Used in bodybuilding community. Theoretical benefits for site-specific muscle growth.

Safety Information

Potential Side Effects

  • Unknown in humans
  • Potential hypoglycemia
  • Injection site reactions

Contraindications

  • Active cancer
  • Pregnancy
  • Breastfeeding

Interactions

  • Synergistic with IGF-1 and growth hormone

Quick Facts

CategoryGrowth Hormone
SourceSynthetic IGF-1Ec splice variant
Legal StatusResearch compound, banned in sports
Gabriel Brain Score
74/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.